Acute Phase Treatment for Infants Younger Than 1 Year of Age with Kawasaki Disease: A Single Center Retrospective Study
Journal Title: Journal of Advanced Research in Medicine - Year 2019, Vol 6, Issue 1
Abstract
Background: Infants younger than 1 year of age with Kawasaki disease (KD) have a high risk for coronary artery lesions (CAL). However, the appropriate acute phase treatment for the infants has not been established. Objective: To ascertain the usefulness of an initial single intravenous immunoglobulin (IVIG) therapy (2g/ kg) with delayed use of aspirin (DUA) for the infants. Materials and Methods: The outcomes in 205 patients who underwent initial single IVIG therapy at 2g/ kg/ dose with DUA for KD were investigated retrospectively. These subjects were divided into those aged <1 year (infant group, n = 43) and those aged 1 year or older (non-infant group, n=162). Statistical analyses were performed using Stat Flex Version 6 for Windows. Chi-square, Fisher’s exact, and Mann-Whitney U tests were used as appropriate, with sample size considerations. Results: Numbers of major signs in infant group were significantly fewer than those in non-infant group (median 5, interquartile range [IQ]: 5-5 vs. 6, IQ: 5-6, P <0.001). The prevalence of incomplete type (20.9% vs. 11.1%, P=0.091), timing of initial IVIG therapy in regards to day of illness onset (median 5, IQ: 5-6 vs. 5, IQ: 5-6, P=0.452), the prevalence of rescue therapies (9.3% vs. 13.6%, P=0.454), and CAL (0.0% vs. 3.1%, P=0.368) were similar between the 2 groups. No infants received steroids and had the CAL 3mm. The prevalence of initial IVIG therapy resistant patients in infant group was significantly lower than that in non-infant group (9.3% vs. 26.5%, P = 0.017). The defervescence days of illness in infant group were significantly earlier than those in non-infant group (median 6, IQ: 6-7 vs. 7, IQ: 6-8, P <0.001). Conclusion: The infants who are treated appropriately may not have a chance to higher risk of large CAL. An initial single IVIG therapy (2 g/kg) with DUA was useful for prevention of CAL 3 mm in infants with KD.
Authors and Affiliations
Toshimasa Nakada
Keywords
Related Articles
- EP ID EP669836
- DOI 10.24321/2349.7181.201901
- Views 101
- Downloads 0
The Need of Vitamin D Supplementation Programme in India
With the aim to alleviate the vitamin D deficiency in Indian population for the achievement of better bone health on the path of holistic health approach.
Acute Stroke as the Initial Presentation of Takayasu Arteritis: Rare but Not Infrequent
Takayasu arteritis is an idiopathic, autoimmune, large vessel vasculitis, mainly affecting the young adults. Its exact etiopathogenesis is not known and it has varied clinical presentations.Acute stroke as initial presen...
Complications and Safety Profile of Posterior SubTenon Injection of Triamcinolone Acetonide
Purpose: Posterior Sub-Tenon injection (PSTI) is a common route of drug delivery for triamcinolone acetonide (TA) for intraocular inflammation. The aim of this study was to evaluate indications, complications and safety...
Carotid Artery Intima Media Thickness in Predicting Coronary Artery Disease in Type II Diabetes Mellitus
Diabetes Mellitus is a chronic, common metabolic disorder characterised by high blood sugar levels over a prolonged period. Atherosclerosis involving the coronary, cerebral and peripheral (lower extremity) arteries is th...
Perioperative Haemostatic Management in a Patient Undergoing Craniotomy for Excision of Meningioma: Role of Thromboelastography
Although there is a general predisposition towards hyper-coagulability during brain tumour surgery, hypocoagulability may exist in certain cases even before surgery, detectable only when the physical characteristics of c...